SABS

SAB BIOTHERAPEUTICS INC

Healthcare | Micro Cap

-$0.17

EPS Forecast

$0.25

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31 soon

Market expectations

EPS Expectation:

-$0.17

Revenue Expectation:

$0.25

EPS Surprise Expectation:

-$0.013

Revenue Surprise Expectation:

-$0

Post-release price volatility - High

Post-release Overnight Move:

±9.1%

Post-release 1-week Move:

±

Expected price impact

If company results match EPS & revs consensus exactly:

1.1%

If company results match Proximilar expectations exactly:

0.6%

Earnings volatility

EPS standard deviation:

$0.18

Revenue standard deviation:

$5

As % of share price:

4.75% EXTREME UNCERTAINTY

As % of market cap:

2.64% HIGH